Assessment of the inferior mesenteric vein diameter as a surrogate marker to evaluate response to neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1318|20|1|75-76

ISSN： 1462-8910

Source： COLORECTAL DISEASE, Vol.20, Iss.1, 2018-01, pp. : 75-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

By  

Oncology, Vol. 85, Iss. 1, 2013-06 ,pp. : 27-32

Karger

Access to resources Recommend Favorite

Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review

By  

COLORECTAL DISEASE, Vol. 17, Iss. 10, 2015-10 ,pp. : 849-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I/II Study of Preoperative Concurrent Chemoradiotherapy with S-1 for Locally Advanced, Resectable Rectal Adenocarcinoma

By  

Oncology, Vol. 81, Iss. 5-6, 2011-12 ,pp. : 306-311

Karger

Access to resources Recommend Favorite

PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

By  

HISTOPATHOLOGY, Vol. 66, Iss. 7, 2015-06 ,pp. : 991-1002

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dynamic contrast‐enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 3, 2015-09 ,pp. : 673-680

John Wiley & Sons Inc

Access to resources Recommend Favorite